SUMMARY The HLA antigen distribution was studied in 37 north Indian patients with myasthenia gravis. The control group consisted of 118 normal, healthy individuals of the same ethnic group. The antigens showing the highest frequency were Bw2l (18-9% vs 4-2% p < 0-005), Bw35 (24-3% vs 6-8%, p < 0.005) and A9 (51-3% vs 30-5%, p < 0.025). HLA-B8 was increased nearly two fold in the myasthenia gravis patients (RR = 2-4) and was confined mainly to the young females without thymoma. The possibility that Bw2l and Bw35 might be the markers for susceptibility to autoimmune disorders in India is discussed. The observations also support those of others that HLA-B8 linked susceptibility gene is more frequently found in myasthenia gravis patients with thymic hyperplasia.
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Epidemiological observations on myasthenia gravis have indicated the familial nature of this disease. ' However, the pattern of inheritance and the pathogenetic significance of the autoantibodies in myasthenic patients are not clear. Several groups have tried to establish the association of myasthenia gravis with HLA antigens. Most of these investigations have been done in individuals of Caucasian origin. A constant finding has been the increased frequency of HLA-B8 antigen particularly in the young females.25 Others, while confirming the association of B8 in female patients, reported the association of HLA-A3 or HLA-A2 in male patients with thymoma or with late onset of disease.67 Both these groups of workers, however, reported decrease of HLA-B7 in myasthenia gravis. This led investigators to believe that there might be two forms of the disease and that their inheritance may be under polygenic control. There is as yet no data available on HLA and myasthenia gravis in Indian patients. This along with our own findings on the association of HLA-Bw21 and Bw35, rather than B8 in patients of insulin-dependent diabetes mellitus8 prompted us to undertake HLA studies in myasthenia gravis patients. The known race specificity of the HLA and disease association provided further impetus for such studies. 
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The association of HLA-B8 in Caucasian female patients with an early onset of myasthenia gravis is well established.5 This study which is the first report on the HLA antigen distribution in north Indian patients with myasthenia gravis indicates that it is strongly associated with HLA-Bw2l (19% vs 4%, RR = 5) and Bw35 (24% vs 7%, RR= 4), HLA-B8 was increased nearly two fold (RR = 2.4) but did not reach statistical significance. This association of Bw2l and Bw35 with myasthenia gravis seems to be specific to the Indian population since the frequency of these antigens in the normal population does not differ significantly in Indians in comparison with Caucasians."' In a recent study of the Japanese myasthenics, Yoshida et al'2 reported an increased incidence of HLA-B12 especially in young females with early disease and thymic hyperplasia. These studies, therefore, emphasise the race specificity of the HLA and disease associations.
Besides myasthenia gravis, HLA-B8 has been reported to be associated with many other autoimmune disorders in Caucasians such as diabetes mellitus, thyrotoxicosis, Addison's disease, coeliac disease. '3 Our earlier studies on Insulin-dependent diabetes mellitus (Type I) conducted on patients of north Indian origin revealed an association with Bw2l and Bw35 rather ran with B8.8 It is possible that in a population like the one under consideration, Bw2l and Bw35 can apparently play the same role as genetic marker as B8 in Caucasians at least so far as the autoimmune disorders are concerned. The similarity in the negative association with HLA-B7 in Caucasians and north Indians indicates that the B-allele conferring protection in myasthenia gravis might be common in several populations.
The observed increased frequency of B8 in the non-thymoma group of patients particularly the females with an early onset of the disease support the hypothesis that the B8 linked susceptibility gene is more frequently found among myasthenia gravis patients with thymic hyperplasia and is related to the early age of onset. Whether this has any influence of the sex-linked factors is not certain since studies exclusively on male myasthenia gravis patients have suggested that the association with B8 is equally strong in males particularly those with age of onset below 35 years. ' 
